Fulcrum Asset Management LLP Purchases 9,166 Shares of Anterix Inc. $ATEX

Fulcrum Asset Management LLP purchased a new stake in shares of Anterix Inc. (NASDAQ:ATEX) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 9,166 shares of the company’s stock, valued at approximately $724,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of ATEX. State of Wyoming bought a new stake in shares of Anterix in the third quarter worth $27,000. Sterling Capital Management LLC increased its position in Anterix by 850.0% during the third quarter. Sterling Capital Management LLC now owns 380 shares of the company’s stock valued at $30,000 after acquiring an additional 340 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Anterix during the second quarter valued at $35,000. Parallel Advisors LLC lifted its holdings in Anterix by 63.7% in the first quarter. Parallel Advisors LLC now owns 933 shares of the company’s stock valued at $36,000 after acquiring an additional 363 shares during the period. Finally, Fifth Third Bancorp bought a new position in Anterix in the first quarter valued at about $64,000. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CMO Heather Martin sold 8,064 shares of the firm’s stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $84.20, for a total value of $678,988.80. Following the transaction, the chief marketing officer directly owned 26,743 shares of the company’s stock, valued at approximately $2,251,760.60. This trade represents a 23.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christopher Guttman-Mccabe sold 23,439 shares of Anterix stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $92.36, for a total value of $2,164,826.04. Following the transaction, the insider owned 44,876 shares in the company, valued at $4,144,747.36. This trade represents a 34.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 78,441 shares of company stock worth $6,794,661 in the last quarter. Company insiders own 40.05% of the company’s stock.

Anterix Price Performance

Shares of Anterix stock opened at $82.69 on Friday. The company’s fifty day simple moving average is $81.22 and its 200-day simple moving average is $67.52. The stock has a market capitalization of $1.63 billion, a PE ratio of 212.03 and a beta of 0.87. Anterix Inc. has a 1-year low of $18.93 and a 1-year high of $113.00.

Anterix (NASDAQ:ATEX) last issued its quarterly earnings data on Tuesday, November 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.05. The firm had revenue of $1.96 million during the quarter, compared to the consensus estimate of $2.05 million. Anterix had a net margin of 96.23% and a negative return on equity of 11.07%. As a group, research analysts anticipate that Anterix Inc. will post -2.00 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. B. Riley Financial raised Anterix from a “neutral” rating to a “buy” rating and raised their target price for the stock from $86.00 to $103.00 in a research report on Thursday. Wall Street Zen lowered shares of Anterix from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Weiss Ratings lowered shares of Anterix from a “hold (c)” rating to a “sell (d+)” rating in a research report on Wednesday. Clear Str upgraded shares of Anterix to a “strong-buy” rating in a research note on Monday, July 27th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Anterix from $133.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $131.33.

Anterix News Roundup

Investors following ATEX have been watching these news items:

• Positive Sentiment: B. Riley raised its rating on Anterix from Neutral to Buy and increased its price target to $103 from $86, pointing to potential spectrum transactions. Anterix upgraded to buy at B Riley on spectrum deal prospects
• Positive Sentiment: Anterix cited 16 active opportunities and $107.5 million in cash, giving it financial flexibility as it pursues deals. Coverage also highlighted the potential value of its spectrum amid scarcity. Anterix signals 16 active opportunities as it stresses cash flexibility and spectrum scarcity
• Negative Sentiment: The company posted a GAAP net loss, while some contract revenue remains uncollected—factors that temper the positive deal and balance-sheet outlook. Why Anterix Stock Climbed Higher Today

Anterix Company Profile

Anterix Inc. provides licensed wireless spectrum for private broadband networks, primarily serving electric, gas and water utilities and other critical-infrastructure organizations. Its business focuses on making 900 MHz spectrum available to customers that want dedicated communications networks for operational needs such as grid monitoring, automation and resilience. The company’s spectrum holdings cover areas across the United States. Anterix works with utilities and technology partners to support the development of private LTE networks, offering spectrum access and related planning and ecosystem support rather than operating a public mobile network.